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Previous microarray analyses revealed that LMO4 is expressed in 3T3-L1 preadipocytes, however, its
roles in adipogenesis are unknown. In the present study, using RT-PCR sequencing and quantitative
real-time RT-PCR, we conﬁrmed that LMO4 gene is expressed in 3T3-L1 preadipocytes and its expres-
sion peaks at the early stage of 3T3-L1 preadipocyte differentiation. Further analyses showed that
LMO4 knockdown decreased the proliferation of 3T3-L1 preadipocytes, and attenuated the differen-
tiation of 3T3-L1 preadipocytes, as evidenced by reduced lipid accumulation and down-regulation of
PPARc gene expression. Collectively, our ﬁndings indicate that LMO4 is a novel modulator of
adipogenesis.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
LIM-only protein 4 (LMO4) belongs to LIM only protein family
of four mammalian nuclear LMO proteins characterized by two
tandem LIM domains and no other functional domains [1]. LMO
proteins function as a molecular adaptor for protein–protein inter-
actions, and all LMO proteins interact with a transcriptional cofac-
tor of LIM domains (Clim)/LIM domain binding protein (Ldb)/
Nuclear LIM interactors (Nli), which has no known enzymatic or
DNA binding activity. LMO/Clim complexes regulate gene expres-
sion via association with LIM homeodomain factors and some
other DNA-binding proteins [1]. LMO proteins play critical roles
in mammalian development and their deregulation is linked to
oncogenesis [2].
LMO4 shares only 50% homology with the LIM domains of other
LMO proteins. It regulates signaling activity and gene expression
by interacting with multiple signaling molecules and transcription
factors [3–7], and plays critical roles in neuron, skin, mammary
gland and retina development. LMO4 is highly expressed in human
breast tumors [8], prostate cancer [9], small cell lung carcinomas
[10] and pancreas cancer [11], and implicated in the cause or pro-
gression of these cancers. LMO4 promotes cell proliferation of sev-
eral breast cancer cell lines and normal mammary epithelial cells[12,13], and inhibits differentiation of mammary epithelial cells
in vitro [8,13].
Adipogenesis involves cell proliferation and differentiation. Adi-
pocyte differentiation is regulated by multiple transcription fac-
tors, coregulators and miRNAs [14–17]. Transcription factor
peroxisome proliferator-activated receptor c (PPARc) and CCAAT/
enhancer-binding protein a (C/EBPa) are recognized as master reg-
ulators of adipogenesis. PPARc and C/EBPa act in concert to orches-
trate the differentiation of preadipocytes into adipocytes. PPARc is
both necessary and sufﬁcient for adipocyte differentiation [15]. Ec-
topic expression of PPARc is sufﬁcient to induce adipocyte differ-
entiation in ﬁbroblasts, and no factor has been reported to
promote adipogenesis in the absence of PPARc [15]. On the other
hand, C/EBPa-deﬁcient cells are capable of cell differentiation
[15]. Recent studies have demonstrated that a number of new tran-
scription factors, coregulators and miRNAs are involved in the reg-
ulation of adipogenesis [18,19].
The mouse 3T3-L1 preadipocyte cell line has been an ideal
in vitro system for dissecting the underlying mechanism of adipo-
genesis [20]. The entire process of 3T3-L1 preadipocyte differenti-
ation consists of several stages. First, proliferating preadipocytes
become growth-arrested by contact inhibition. Second, after hor-
mone induction, the growth-arrested 3T3-L1 preadipocytes reenter
the cell cycle and undergo several rounds of cell division, a process
known as mitotic clonalexpansion (MCE). Finally, after MCE, the
cells become quiescent and express genes which lead to terminal
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LMO4 is expressed in 3T3-L1 preadipocytes, and its expression
peaks on day 1 of 3T3-L1 preadipocyte differentiation [22,23].
Moreover, a recent genome-wide proﬁling of histone H3 lysine
56 (H3K56) acetylation in human mesenchymal stem cell-derived
adipocytes revealed that LMO4 gene is highly acetylated at H3K56
[24]. Together, these data suggest the existence of a biological rel-
evance of LMO4 in adipogenesis. However, the role and signiﬁ-
cance of LMO4 in adipogenesis has not been explored in vitro. In
the present study, we ﬁrst conﬁrmed LMO4 expression in 3T3-L1
preadipocytes by RT-PCR and sequencing, and then investigated
therole of LMO4 in the proliferation and differentiation of 3T3-L1
preadipocytes using siRNA approach. Our ﬁndings indicate LMO4
modulates proliferation and differentiation of 3T3-L1
preadipocytes.2. Materials and methods
2.1. Cell culture and differentiation
Mouse 3T3-L1 preadipocytes were purchased from Institute of
Biochemistry and Cell Biology, Chinese Academy of Sciences, and
were grown in Dulbecco’s modiﬁed Eagle’s medium (no pyruvate,
high glucose formulation; Gibco-BRL) supplemented with 10% heat
inactivated fetal bovine serum (FBS; Gibco) and incubated in a
humidiﬁed atmosphere of 5% CO2 at 37 C, with media changes
every other day. For 3T3-L1 differentiation, 3T3-L1 preadipocytes
were grown to conﬂuence, two days after reaching conﬂuence,
cells were induced to differentiate (designated as day 0) by adding
standard differentiation cocktail (DMI) consisting of 1 lM dexa-
methasone (Dex) (Sigma–Aldrich), 0.5 mM 1-methyl-3-isobutyl-
xanthin (IBMX) (Sigma–Aldrich) and 10 lg/ml insulin (Sigma–Al-
drich) to the culture medium. After 2 days, the medium was re-
placed with DMEM containing 10% FBS and 10 lg/ml insulin, and
the cells were incubated for another 2 days. Thereafter, until the
cells were fully differentiated, the cells were maintained in DMEM
with 10% FBS, with media changes every other day.
2.2. RNA isolation, cDNA synthesis and cloning
Total RNA was isolated from proliferating or differentiating
3T3-L1 preadipocytes using Trizol reagent (Invitrogen) following
the manufacturer’s instructions, and RNA quality was assessed by
agarose gel electrophoresis. The cDNA synthesis was performed
by using 1 lg of total RNA, oligo (dT) primer (Promega), and re-
verse transcriptase (Promega) according to the manufacturer’s pro-
tocol. The cDNAs were subjected to partial cloning and subsequent
quantitative real-time PCRs. PCR conditions for the partial cloning
of LMO4 cDNA were 95 C for 5 min, followed by 30 cycles of 94 C
for 30 s, 55 C for 30 s, and 72 C for 30 s, and ﬁnally a cycle at 72 C
for 10 min. Ex Taq polymerase (TaKaRa, Dalian, China) was used for
PCR ampliﬁcation of LMO4. Primer sequences for cloning the par-
tial cDNA of mouse LMO4 were as follows: sense 50-GAC-
CGCTTTCTGCTCTATG-30, antisense 50-AGTAGTGGATTGCTCTGAAG-
30. The PCR products were separated by electrophoresis on a 1.5%
agarose gel, gel puriﬁed using an AxyPrep™ DNA Gel Extraction
Kit (AxyPrep Biosciences), and cloned into pMD18T-Vector (TaKa-
Ra, Dalian, China) and sequenced (Invitrogen).
2.3. siRNA oligoduplexes and transfection
Small interfering RNA (siRNA) oligo for LMO4 and negative con-
trol were synthesized and annealed by GenePharma (Shanghai,
China). The sequences of each oligoduplex were as follows:
LMO4-speciﬁc siRNA (siLMO4), 50-GAUCGGUUUCACUACAUCAdTdT-30, and negative control siRNA (ncLMO4), 50- GUCCAUUU-
CUCGGCGUUAAdTdT-30. 3T3-L1 preadipocytes were transfected
with siLMO4 or ncLMO4 using DharmaFECT3 (Dharmacon) accord-
ing to the manufacturer’s protocols. Transfection efﬁciency was as-
sessed by real-time PCR analysis of LMO4 expression levels in the
transfected cells.
2.4. Quantitative real-time PCR
Real-time PCR was performed on a 7500 real-time PCR System
(Applied Biosystem) using SYBR Premix Ex Taq (TaKaRa, Dalian,
China). The PCR conditions were 95 C for 10 s, followed by 40
cycles of 95 C for 5 s and 60 C for 34 s. The primer sequences
usedfor quantitative real-time PCR were as follows: LMO4 (sense
50-GACCGCTTTCTGCTCTATG-30, antisense 50-AGTAGTGGATTGCTC
TGAAG-30), cyclin D1 (sense 50-GCGTACCCTGACACCAATC-30, anti-
sense 50-CCTCCTCTTCGCACTTCTG-30), cyclin E (sense 50-GCCTCG
GAAAATCAGACCA-30, antisense 50-CCATTAGCCAATCCAGAAGAAC-30,
Cullin-3 (sense 50-CGGGATATTGGCCTACTCA-30, antisense 50-GAC-
CATAAAAGGTGGCATTG-30), C/EBPb (sense 50- TTTCGGGACTT-
GATGCAATC-30, antisense 50-CGCAGGAACATCTTTAAGGTGT-30),
PPARc (sense 50-CGGTTTCAGAAGTGCCTTC-30, antisense 50-CCGCCA
ACAGCTTCTCCTT-30), aP2 (sense 50-TGAAGAGCATCATAACCCTA-30,
antisense 50-TCATAACACATTCCACCACC-30), b-actin (sense 50-GCC
ACATCGCTCAGACAC-30, antisense 50-CATCACGCCACAGTTTCC-30).
All the primers were designed to span genomic introns to avoid
the ampliﬁcation of contaminated genomic DNA. Gene expression
was normalized with b-actin expression level. Quantitative real-
time PCR analyses were performed in triplicates and repeated at
least three times.
2.5. Protein isolation and Western blot analysis
Cultured cells were washed twice with PBS, and lysed using
RIPA Buffer (Beyotime Institute of Biotechnology, Jiangsu, China)
supplemented with 1% Phenylmethanesulfonyl ﬂuoride (PMSF;
Beyotime Institute of Biotechnology). Lystates were fractionated
on 12.5% SDS–PAGE gel and transferred onto Immun-Blot PVDF
membranes (Millipore). The membranes were blocked with 5%
nonfat dry milk in PBST (PBS with 0.05% Tween-20) for 1 h at
room temperature, and immunoblotted with primary antibodies
against cyclin D1 (1:1000 dilution; Beyotime Institute of Biotech-
nology, Jiangsu, China) or b-actin (1:1000 dilution; Beyotime
Institute of Biotechnology, Jiangsu, China) at room temperature
for 1 h. The blots were washed four times with PBST, incubated
with goat anti-mouse IgG conjugated with horseradish peroxi-
dase (1:5000) (ZSGB-BIO, Beijing, China) in PBST for 1 h at room
temperature, and then washed four times with PBST for 20 min.
The immunoreactive bands were visualized using an ECL Plus
detection kit (HaiGene Biotechnology, Harbin, China) and ex-
posed to X-ray ﬁlm. Each Western blot was performed at least
three times.
2.6. Cell proliferation assay
Cell proliferation was assessed by MTT assay. 3T3-L1 preadipo-
cytes were seeded at a density of 2500 cells/well into 96-well
plates in culture medium. After 24 h of culture, cells were transfec-
ted with siLMO4 or ncLMO4. At each designated time points after
transfection, 20 ll MTT reagent (5 mg/ml; Invitrogen) was added
to each well and incubated for 4 h at 37 C in the dark. Following
the incubation, culture medium was replaced with DMSO
(150 ll/well), and plates were vibrated for 10 min. When MTT-for-
manzan crystals were solubilized, the absorbance was measured at
a wavelength of 490 nm with an ELISA plate Reader.
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Culture medium was removed from the plate and cells were
washed twice with PBS and ﬁxed in 10% paraformaldehyde in
PBS for 30 min at room temperature. Then cells were rinsed three
times with PBS and distilled water, and stained with Oil Red O
staining solution (0.5% Oil Red O in isopropanol, diluted 3:2 in
water and ﬁltered with a 0.22 lm ﬁlter), at room temperature for
40 min. After staining, the cells were washed three times with
PBS and photographed. Alternatively, for a quantitative assay, Oil
Red O dye was extracted with isopropanol and the absorbance
was measured at 510 nm wavelength with a UV spectrophotome-
ter (Ultrospec 1000, Biochrom Ltd., Cambridge, UK).2.8. Statistical analysis
The results are presented as means ± standard deviations.
Student’s two tailed t-test was performed for comparison of differ-
ences between experimental and control groups. A P value of <0.05
(⁄) was considered signiﬁcant; a P value of <0.01 (⁄⁄), very
signiﬁcant.3. Results
3.1. Expression of LMO4 in 3T3-L1 preadipocytes
Microarray gene expression analysis revealed that LMO4 was
expressed in 3T3-L1 preadipocytes [22,23]; however, this ﬁnding
has not yet been validated by other techniques. Therefore, we
ﬁrst validated LMO4 gene expression in 3T3-L1 preadipocyte
samples using RT-PCR and sequencing. Based on LMO4 mRNA
sequence (NM_001161769.1), we designed a pair of speciﬁc
primers for LMO4 mRNA expression and performed RT-PCR using
the total RNA extracted from three randomly chosen samples of
3T3-L1 preadipocytes. RT-PCR products yielded the expected
ampliﬁed fragment of 248 bp in all the three samples (Fig. 1A).
Sequence analysis showed that the ampliﬁed fragment shared
99.5% identity with LMO4 mRNA sequence (NM_001161769.1)
(Fig. 1B). Taken together, our data conﬁrm that LMO4 is ex-
pressed in 3T3-L1 preadipocytes. There was one single nucleotide
difference between the ampliﬁed LMO4 RT-PCR fragment and
LMO4 mRNA sequence. The nucleotide difference was located in
the coding region of LMO4 gene and caused an amino acid change
of serine to proline at residue 152. The amino acid change, which
was located at the extreme C-terminus of LMO4, did not reside in
any known functional domains and sites of LMO4, including LIM
domains, Lbd1 binding site, and Zn binding site.Fig. 1. Expression of LMO4 in 3T3-L1 preadipocytes. (A) Reverse transcription-PCR a
preadipocytes. M: DL2000 marker; lanes 1–3: LMO4 RT-PCR products from three random
LMO4 RT-PCR product and mouse LMO4 mRNA sequence (NM_001161769). Conserved n
open boxes.3.2. Impact of LMO4 knockdown on proliferation of 3T3-L1
preadipocytes
Adipogenesis involves in cell proliferation and differentiation.
In order to investigate the functional roles of LMO4 in 3T3-L1
adipogenesis, we ﬁrst used small interfering RNA (siRNA) to assess
the role of LMO4 in the proliferation of 3T3-L1 preadipocytes.
Before we performed the experiment, we functionally tested trans-
fection efﬁcacy of siRNA-mediated knockdown of LMO4. Quantita-
tive real-time RT-PCR analysis showed that transfection with
LMO4-speciﬁc siRNA (siLMO4) signiﬁcantly reduced LMO4 mRNA
expression in 3T3-L1 preadipocytes at 48 h after transfection, on
average, by around 80% compared with the control siRNA
(ncLMO4), (P < 0.01; Fig. 2A), conﬁrming the utility of this ap-
proach. We then addressed whether LMO4 regulates proliferation
of 3T3-L1 preadipocytes by siRNA-mediated suppression of
LMO4. The impact of LMO4 silencing on 3T3-L1 preadipocyte pro-
liferation was assessed using the MTT assay. As shown in Fig. 2B,
siLMO4 signiﬁcantly reduced cell proliferation in proliferating
3T3-L1 preadipocytes on days 2, 3, and 4 post siRNA transfection,
compared to ncLMO4 (P < 0.05). LMO4 promotes cell proliferation
of several breast cancer cell lines and normal mammary epithelial
cells [12,13]. Recently, it has been shown that LMO4 is a general
cell cycle regulator, and it is required for sustained expression of
key cell cycle regulators: cyclin D1 and cullin-3 [25]. To understand
the underlying mechanism by which LMO4 regulates 3T3-L1 prea-
dipocyte proliferation, we evaluated the impact of LMO4 knock-
down on the expression of cyclin D1, cyclin E and cullin-3 in
3T3-L1 preadipocytes using quantitative real-time RT-PCR. The re-
sults showed that LMO4 knockdown signiﬁcantly reduced the
mRNA expression of cyclin D1 compared to ncLMO4 (P < 0.05;
Fig. 2C). We also observed a trend for decreasing expression of
cyclin E and cullin-3 in siLMO4-transfected cells compared to
ncLMO4-transfected cells, but the differences did not reach statis-
tical signiﬁcance (P > 0.05; Fig. 2C). Consistently, Western blot
analysis also conﬁrmed that LMO4 Knockdown reduced cyclin D1
expression (Fig. 2D). Our ﬁndings suggest that LMO4 may promote
proliferation of 3T3-L1 preadipocytes via upregulation of cyclin D.
Overall, these results demonstrate that LMO4 knockdown inhibits
proliferation of 3T3-L1 preadipocytes and suggest its involvement
in the regulation of 3T3-L1 preadipocyte proliferation.
3.3. LMO4 expression pattern during adipocyte differentiation of 3T3-
L1 preadipocytes
Microarray analysis showed that LMO4 expression peaked on
day 1 of 3T3-L1 preadipocyte differentiation [22,23]. To conﬁrm
the microarray results, we analyzed LMO4 expression pattern dur-nalysis of LMO4 mRNA expression in three randomly chosen samples of 3T3-L1
ly chosen samples of 3T3-L1 preadipocytes. (B) Sequence alignment of the ampliﬁed
ucleotides are indicated as vertical lines, and nucleotide differences are indicated as
Fig. 2. LMO4 knockdown reduces 3T3-L1 preadipocyte proliferation. (A) Quantitative real-time RT-PCR analysis for LMO4 mRNA knockdown efﬁciency in 3T3-L1
preadipocytes. After transfection with LMO4-speciﬁc siRNA (siLMO4) or negative control siRNA (ncLMO4), 3T3-L1 preadipocytes were cultured for 48 h. Total RNA was
extracted, and gene expression was analyzed by quantitative real-time RT-PCR, and expression levels were normalized to b-actin, and the results were expressed as
means ± standard deviations for three independent wells. (B) The Impact of LMO4 knockdown on 3T3-L1 preadipocyte proliferation. 3T3-L1 preadipocytes were transfected
with siLMO4 or ncLMO4, respectively, and MTT assay was used to evaluate the proliferation of 3T3-L1 preadipocytes at the designated time points. Results were presented as
means ± standard deviations for ﬁve independent wells. (C) Impact of LMO4 knockdown on the expression of cyclin D1, cyclin E, and cullin-3 in 3T3-L1 preadipocytes. 3T3-L1
preadipocytes were transfected with siLMO4 or ncLMO4, and gene expression was analyzed by quantitative real-time RT-PCR. Expression levels were normalized to b-actin,
and the results were expressed as means ± standard deviations for three independent wells. (D) Western blotting analysis of the impact of LMO4 knockdown on cyclin D1
protein expression in 3T3-L1 preadipocytes. b-Actin was used as a protein loading control. Asterisk (⁄) indicates P < 0.05; double asterisks (⁄⁄) indicates P < 0.01 in Student’s
two tailed t-test.
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tative real-time RT-PCR. As expected, the early differentiation
marker gene, C/EBPb, was highly expressed at the early stage of
adipocyte differentiation, and the late differentiation marker
genes, PPARc and aP2, were highly expressed at the late stage of
differentiation (Fig. 3), evidencing for successful adipogenic differ-
entiation. As shown in Fig. 3, quantitative real-time RT-PCR analy-
sis revealed that LMO4 expression peaked on day 1 of 3T3-L1
differentiation (eightfold and fourfold increases compared to day
0 and day 2, respectively), which conﬁrmed the previous
microarray result [22,23].
3.4. Impact of LMO4 knockdown on 3T3-L1 preadipocyte
differentiation
LMO4 expression ﬂuctuates during 3T3-L1 preadipocyte differ-
entiation, suggesting LMO4 may play a role in preadipocyte differ-
entiation. To explore the role of LMO4 in 3T3-L1 preadipocyte
differentiation, we explored the impact of LMO4 knockdown on
3T3-L1 preadipocyte differentiation using oil red O staining for
lipid droplets. As shown in Fig. 4A and B, Oil red O staining and
its quantiﬁcation clearly showed that LMO4 knockdown attenu-
ated 3T3-L1 preadipocyte differentiation from day 4 onward, as
demonstrated by the presence of fewer lipid accumulating cells.
Consistent with oil red O staining results, at day 8 of preadipocytedifferentiation, PPARc mRNA expression was reduced in siLMO4-
transfected cells compared with ncLMO4-tranfected cells
(Fig. 4C) (P < 0.05). Taken together, our data indicate that LMO4
knockdown partially inhibits 3T3-L1 preadipocyte differentiation,
thus suggesting that LMO4 is a positive regulator of 3T3-L1 prea-
dipocyte differentiation.
4. Discussion
In the present study, we conﬁrmed the previous microarray re-
ports that the LMO4 is expressed in 3T3-L1 preadipocytes and
demonstrated that LMO4 knockdown decreases the proliferation
of 3T3-L1 preadipocytes, and attenuates 3T3-L1 preadipocyte dif-
ferentiation. To our knowledge, this is ﬁrst report that LMO4 mod-
ulates proliferation and differentiation of 3T3-L1 preadipocytes.
Previous studies have shown that LMO4 regulates cell prolifer-
ation in mammary gland development and several breast cancer
cell lines [12,13]. Mammary gland-speciﬁc knockout LMO4 results
in reduced lobuloalveolar development with a concomitant de-
crease in cell proliferation [26], and targeted overexpression of
LMO4 in mouse mammary glands induceshyperplasia and tumors
[13]. Moreover, the expression of the Engrailed-LMO4 fusion pro-
tein inhibits cell growth of human normal mammary epithelial
cells [12]. Silencing of LMO4 in several breast cancer cell lines
and HEK-293T leads to markedly reduced proliferation, accompa-
Fig. 3. The mRNA expression of LMO4 and adipocyte differentiation marker genes (C/EBPb and PPARc) during 3T3-L1 preadipocyte differentiation. Gene expression was
analyzed by quantitative real-time RT-PCR. Expression levels were normalized to b-actin, and the results were expressed as mean ± standard deviations for three independent
wells.
Fig. 4. Impact of LMO4 knockdown on 3T3-L1 preadipocyte differentiation. (A) Oil Red O staining of 3T3-L1 preadipocytes transfected with siLMO4 or ncLMO4 at the
designated time points after differentiation. (B) Quantiﬁcation of lipid accumulation in the differentiating 3T3-L1 preadipcytes on days 0, 4, and 8 of differentiation. (C) Impact
of LMO4 knockdown on the expression of adipocyte differentiation marker genes. 3T3-L1 preadipocytes transfected with siLMO4 or ncLMO4, were induced to differentiate
with DMI, total RNA was extracted at the designated time points after differentiation. Gene expression was analyzed by quantitative real-time RT-PCR. Expression levels were
normalized to b-actin and the results were expressed as means ± standard deviations for three independent wells. Asterisk (⁄) indicates P < 0.05; double asterisks (⁄⁄) indicates
P < 0.01 in Student’s two tailed t-test.
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cullin-3 [25]. Further investigation of the molecular mechanism
of proliferative effect of LMO4 in the these cells revealed that
LMO4 is a cell cycle regulator, which is required for proliferation
and necessary for sustained expression of several key cell cycle
regulators including cyclin D1 [25]. Consistent with these previous
studies, we observed that LMO4 knockdown decreased prolifera-
tion of 3T3-L1 preadipocytes, accompanied bydown-regulation of
cyclin D1, cyclin E and cullin-3. Our ﬁnding provides further
evidence that LMO4 is a general cell cycle regulator.
Overexpression of LMO4 or its binding partner Ldb1 inhibits the
differentiation of mammary epithelial cells [8]. In present study,
we demonstrated that LMO4 knockdown led to partial inhibition
of 3T3-L1 preadipocyte differentiation. We did not address the
molecular mechanisms by which LMO4 regulates 3T3-L1 preadipo-
cyte differentiation. There are at least two possible explanations
for the partial inhibition 3T3-L1 preadipocyte differentiation by
LMO4 knockdown. First, PPARc is the master regulator of adipo-
cyte differentiation, and a previous study has shown that LMO4
interacts in a ligand-dependent manner with PPARc and promotes
PPARc-dependent gene activation in neurons [3]. Thus, it is possi-
ble that LMO4 knockdownmay interfere with the functional activ-
ity of PPARc during adipocyte differentiation, resulting in the
partial inhibition of 3T3-L1 adipocyte differentiation. Alternatively,
MCE is a key event for initiating differentiation of 3T3-L1 preadipo-
cytes into adipocytes [21]. LMO4 is a general cell cycle regulator
[25], and its expression peak coincided with the onset of MCE of
3T3-L1 preadipocyte differentiation. LMO4 knockdown may inter-
fere with MCE, leading to attenuation of 3T3-L1 preadipocyte
differentiation.
Recently, LMO4 has been proved to be a novel modulator of
leptin signaling in the hypothalamus and to regulate fatmetabolism
[27]. Together with our ﬁndings, these data suggest that LMO4
regulates energy homeostasis and fat metabolism at different levels
and that LMO4may be a potential targetfor future therapy for obes-
ity. Future studies will focus on the molecular mechanisms by
which LMO4 regulates the adipogenesis of 3T3-L1 preadipocytes.
In conclusion, although further studies are required to elucidate
the molecular mechanisms underlying LMO4-mediated preadipo-
cyte differentiation, our ﬁndings clearly identify LMO4 as a novel
modulator of adipogenesis in 3T3-L1 preadipocytes.
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